Ionis Pharmaceuticals IONS
NASDAQ IONS
$58.61 +0.48 (+0.83%)
As of: Sep 4, 2026 · 1:35 PM EDT

Ionis Pharmaceuticals (IONS) Equity Income (2010 - 2012)

Analysis

Ionis Pharmaceuticals (IONS) Equity Income (2010 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn -
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn -
8 Royalty Pharma 28.44 Bn 27.60 Bn - 4.08 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -
10 Ionis Pharmaceuticals 9.70 Bn 7.64 Bn 265.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 -267,000.00
Jun 30, 2012 -163,000.00
Mar 31, 2012 -976,000.00
Dec 31, 2011 -1.28 Mn
Sep 30, 2011 -386,000.00
Jun 30, 2011 -1.03 Mn
Mar 31, 2011 -856,000.00
Dec 31, 2010 -521,000.00
Sep 30, 2010 -930,000.00
Jun 30, 2010 -3.94 Mn
Mar 31, 2010 -1.49 Mn